FERRANTINI, CECILIA
 Distribuzione geografica
Continente #
NA - Nord America 5.191
EU - Europa 5.107
AS - Asia 986
AF - Africa 19
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.309
Nazione #
US - Stati Uniti d'America 5.183
PL - Polonia 2.237
RU - Federazione Russa 1.269
IT - Italia 595
IE - Irlanda 372
SG - Singapore 287
SE - Svezia 257
CN - Cina 232
HK - Hong Kong 223
JO - Giordania 110
CH - Svizzera 91
VN - Vietnam 70
FI - Finlandia 58
GB - Regno Unito 51
IN - India 50
BE - Belgio 39
DE - Germania 38
FR - Francia 28
CI - Costa d'Avorio 18
ES - Italia 17
GR - Grecia 12
UA - Ucraina 12
NL - Olanda 9
CA - Canada 8
KR - Corea 8
RO - Romania 8
LU - Lussemburgo 6
NO - Norvegia 3
TR - Turchia 3
CO - Colombia 2
JP - Giappone 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EU - Europa 1
HU - Ungheria 1
IR - Iran 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 11.309
Città #
Warsaw 2.234
Santa Clara 915
Fairfield 669
Chandler 368
Dublin 363
Ashburn 325
Woodbridge 322
Seattle 292
Cambridge 249
Florence 245
Houston 240
Singapore 236
Ann Arbor 202
Wilmington 193
Hong Kong 153
Altamura 113
Lawrence 111
Bern 89
Princeton 88
Beijing 82
Buffalo 63
Dong Ket 62
Boston 53
Shanghai 53
San Diego 52
Moscow 46
Mumbai 41
Medford 39
Brussels 38
Boardman 37
New York 34
Kent 23
Norwalk 21
Helsinki 20
Munich 20
Redwood City 19
Abidjan 18
Phoenix 18
Poggio A Caiano 17
Rome 17
Barcelona 16
Falls Church 14
Los Angeles 14
Milan 13
Andover 12
Dearborn 12
Siena 10
Yubileyny 10
Guangzhou 9
London 9
Redmond 9
Hillsboro 8
Council Bluffs 6
Santa Maria A Monte 6
Saronno 6
Castelliri 5
Nanjing 5
Seoul 5
Toronto 5
Amsterdam 4
Bologna 4
Cagliari 4
Chennai 4
Cleveland 4
Hebei 4
Jacksonville 4
Kilburn 4
Lappeenranta 4
Las Vegas 4
Timisoara 4
Washington 4
West Jordan 4
Oderzo 3
Oslo 3
Prato 3
Pune 3
Richmond 3
Salerno 3
Sesto Fiorentino 3
Bagno a Ripoli 2
Bogotá 2
Bolzano 2
Catania 2
Cesena 2
Cividate Camuno 2
Falkenstein 2
Fucecchio 2
Gangnam-gu 2
Gavirate 2
Gdansk 2
Greenwich 2
Heze 2
Izmir 2
Jinhua 2
Karlsruhe 2
La Veta 2
Laurel 2
Leawood 2
Lecce 2
Molfetta 2
Totale 8.469
Nome #
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 330
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. 281
Atrial Remodeling in Hypertrophic Cardiomyopathy 280
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 260
Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling 248
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 238
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 235
Effect of troponin Ca2+ binding properties on the kinetics of myofibril force initiation and relaxation 210
Mechanical and Energetic Consequences of HCM-Causing Mutations 209
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 208
T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure. 206
Electrical defects of the transverse-axial tubular system in cardiac diseases 204
The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM 196
Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy 195
β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy 190
A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study 186
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 177
Altered Ca2+ and Na+ homeostasis in human hypertrophic cardiomyopathy: Implications for arrhythmogenesis 170
Design of muscle contraction assist devices by liquid crystalline elastomers 165
Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction 164
Interplay between sub-cellular alterations of calcium release and T-tubular defects in cardiac diseases 158
The Missense E258K-MyBP-C Mutation Increases the Energy Cost of Tension Generation in Both Ventricular and Atrial Tissue from HCM Patients 158
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study 157
The missense E258 K-MyBP-C mutation increases the energy cost of tension generation in both ventricular and atrial tissue from HCM patients 151
Impact of Mavacamten on Force Generation in Single Myofibrils from Rabbit Psoas and Human Cardiac Muscle 148
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair 147
Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human induced pluripotent stem cells 144
Real-time optical manipulation of cardiac conduction in intact hearts 140
The relation between sarcomere energetics and the rate of isometric tension relaxation in healthy and diseased cardiac muscle 136
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 135
Advanced Morpho-Functional Analysis on Ventricular and Atrial Tissue Reveals Cross-Bridge Kinetics Alterations and Sarcomere Energetic Impairment in Hcm Patients 134
Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy 132
The transverse-axial tubular system of cardiomyocytes. 130
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 128
EFFECTS OF MAVACAMTEN, A FIRST-IN-CLASS INHIBITOR OF SARCOMERIC MYOSINS, ON THE MECHANICS OF ATRIAL AND VENTRICULAR MAMMALIAN MYOCARDIUM AND FAST SKELETAL MUSCLE 127
Arrhythmia susceptibility in a rat model of acute atrial dilation 126
R4496C RyR2 mutation impairs atrial and ventricular contractility 124
Beta-Blockers for Prevention of Exercise-induced Left Ventricular Outflow Obstruction in Patients with Hypertrophic Cardiomyopathy 124
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 122
Microled Illumination Towards Liquid Crystalline Elastomers Based Cardiac Contraction Assistance 121
Cardiomyocyte-specific Gq signalling and arrhythmias: Novel insights from DREADD technology 120
Action potential propagation in transverse-axial tubular system is impaired in heart failure 116
Functional cardiac imaging by random access microscopy 114
Reply to entcheva: The impact of T-tubules on action potential propagation in cardiac tissue 109
Time resolved depression of isometric force by Mavacamten in single myofibrils from rabbit psoas and human cardiac muscle 108
Response to Letter Regarding Article, "Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy" 108
Impact of detubulation on force and kinetics of cardiac muscle contraction 105
Whole heart cytoarchitecture at micron-scale resolution 105
Design of Biocompatible Liquid Cristal Elastomers Reproducing the Mechanical Properties of Human Cardiac Muscle 105
Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples. 104
Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure 104
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 101
The HCM-associated cardiac Troponin T mutation K280N accelerates tension generation and relaxation in human cardiac myofibrils 99
Impact of RyR2 mutation responsible for Cathecolaminergic Polymorphic Ventricular Tachycardia (CPTV) on the short term interval-force relationship of atrial and ventricular myocardium 95
Targets for therapy in sarcomeric cardiomyopathies. 94
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 93
EFFECTS OF CHRONIC ATRIAL FIBRILLATION ON ACTIVE AND PASSIVE FORCE GENERATION IN HUMAN ATRIAL MYOFIBRILS 90
Impact of R4496C RyR2 mutation on myocardial contractility 90
3D imaging and morphometry of the heart capillary system in spontaneously hypertensive rats and normotensive controls 89
Quantification of Myocyte Disarray in Human Cardiac Tissue 89
Letter to the Editor 87
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 85
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 80
Structural Mapping of Action Potential Propagation Pathways through Healthy and Diseased Heart 80
The harder the climb the better the view: The impact of substrate stiffness on cardiomyocyte fate 80
The HCM-Associated Cardiac Troponin T Mutation K273N Accelerates Tension Generation and Relaxation in Human Cardiac Myofibrils 79
Myocardial dysfunction in hypertrophic cardiomyopathy (HCM): primary effects of sarcomeric protein mutations versus secondary E-C coupling remodeling 78
Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle 77
Age-related decline in contractile function of ventricular myofibrils from HCM patients carrying MYBPC3 mutations 76
[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling] 74
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: Genetic basis, functional consequences and relation to sudden cardiac death 74
1473Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study 73
Optogenetics gets to the heart: A guiding light beyond defibrillation 72
T-tubule remodeling in human hypertrophic cardiomyopathy 72
Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations 72
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 70
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 68
Novel pharmacological approaches for paediatric hypertrophic cardiomyopathy 67
Photoresponsive Polymer-Based Biomimetic Contractile Units as Building Block for Artificial Muscles 63
Myosin Binding Protein-C Mutations responsible for Hypertrophic Cardiomyophaty impair relaxation in human cardiac myofibrils 62
Alpha and beta myosin isoforms and human atrial and ventricular contraction 62
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 57
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 57
Mavacamten depresses human atrial contractility in the same EC50% range as human ventricle 56
Impact of E163R cTnT mutation on cardiac mechanics and energetics in a murine model 55
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms 53
Contraction and electrophysiological abnormalities in myofilament mutation-positive and mutation-negative human HCM myocardium 53
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 51
null 49
Novel method of obtaining myofibrils from cardiomyocyte cultures 49
Sealing t-tubules increases the energy cost of cardiac contraction 49
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 47
Novel Optics-Based Approaches for Cardiac Electrophysiology: A Review 44
The Role of Crosslinker Molecular Structure on Mechanical and Light-Actuation Properties in Liquid Crystalline Networks 41
Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes 39
Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. 33
Myosin isoform-dependent effect of omecamtiv mecarbil on the regulation of force generation in human cardiac muscle 30
NaV1.8: a novel contributor to cardiac arrhythmogenesis in heart failure 25
Totale 11.471
Categoria #
all - tutte 31.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.516 0 0 0 0 250 196 211 244 210 156 208 41
2020/20211.771 126 178 29 182 177 152 119 122 149 372 71 94
2021/2022743 34 35 62 24 54 41 38 42 39 53 125 196
2022/20231.860 160 329 97 104 129 281 211 104 269 20 51 105
2023/2024840 36 81 101 40 61 109 49 199 17 44 46 57
2024/20252.957 189 561 310 741 1.156 0 0 0 0 0 0 0
Totale 11.471